About usOur ApproachOur PipelinePatientsInvestorsCareers

You are leaving Spyre

If you would like to proceed, click the link to continue.
https://twitter.com/

Go back
Continue
Spyre is not responsible for content on external websites.
Please review their Privacy Policy.

Meet our Team

Our team has deep experience developing and commercializing treatments across a broad range of diseases, and is committed to improving the lives of patients.
Our Team

Innovators behind the vision

Leadership
Board of Directors
Scott Burrows

Scott Burrows

Chief Financial Officer
Jonathan Campbell

Jonathan Campbell

VP, Corporate Controller
Irving Cassidy

Irving Cassidy

VP, Medical Affairs
Brian Connolly

Brian Connolly

Chief Technical Officer
Melissa Cooper

Melissa Cooper

SVP, People
Cristina Damatarca

Cristina Damatarca

SVP, Drug Safety and Pharmacovigilance
Paul Fehlner

Paul Fehlner

SVP, Chief Intellectual Property Counsel
Joshua Friedman

Joshua Friedman

SVP, Clinical Development
Janet Gunzner-Toste

Janet Gunzner-Toste

SVP, Operations
MiRa Huyghe

MiRa Huyghe

SVP, Development Operations
Dimitrios Kandylas

Dimitrios Kandylas

VP, Deputy Corporate General Counsel
Heidy King-Jones

Heidy King-Jones

Chief Legal Officer and Corporate Secretary
Justin LaFountaine

Justin LaFountaine

SVP, Corporate Development
Eric McIntyre

Eric McIntyre

VP, Finance and Investor Relations
James Myers

James Myers

VP, Quality and Compliance
Deanna Nguyen

Deanna Nguyen

SVP, Clinical Development
Ivan Noches

Ivan Noches

VP, Information Technology
Mark Rose

Mark Rose

VP, DMPK and Non-clinical Safety
Sheldon Sloan

Sheldon Sloan

Chief Medical Officer
Andrew Spencer

Andrew Spencer

SVP, Preclinical Research and Development
Cameron Turtle

Cameron Turtle

Chief Executive Officer
Matthew Zinder

Matthew Zinder

VP, Regulatory Affairs